Sales orders, purchases, inventory movements and returns should post directly into the general ledger and subledgers. This setup cuts manual reconciliation and supports better margin analysis by style ...

Tranzpay, a leading provider of unified digital payment solutions for the insurance industry, has announced a strategic partnership with INTX,a rapidly growing modern core system provider, today ...

Belfast-based platform reaches global audience with 19 million views across 800+ curriculum-aligned videos, serving young learners in every country worldwide Seeing our content reach children in ...

Belfast-based educational content provider offers teachers, parents and schools free access to one of the UK’s most comprehensive curriculum-aligned collections Quality education should be accessible ...

The latest iMac G3–style Apple Watch concept looks so polished that it could pass for an official product shot, right down to ...

On a set of broken clay bowls from northern Mesopotamia, delicate flower patterns have turned out to be something far more radical than decoration. New analysis of this ancient art suggests that early ...

The Outlet Shoppes at Gettysburg isn’t just another stop on Pennsylvania’s retail landscape – it’s a destination where savvy shoppers make pilgrimages with empty trunks and return with them gloriously ...

Ever found a mysterious coin and wished you could instantly know what it is? You’re about to discover something amazing: your ...

Armagh-based Lyxity introduces IP-protected Intelligent Content technology as AI-powered content market surges past £2.8 billion globally We’ve seen clients cut their content creation time from 100 ...

Trapped in a hell he helped make, a lone hacker aboard a space station far from home sneaks and fights his way through horrible mutants and killer robots in order to take down the monstrous artificial ...

Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca's top-selling respiratory drug Symbicort, although launch plans remain uncertain ...

A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto. The US Court of Appeals for ...